KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oscar Health (OSCR) Cash & Current Investments (2020 - 2025)

Oscar Health's Cash & Current Investments history spans 6 years, with the latest figure at $4.0 billion for Q4 2025.

  • For Q4 2025, Cash & Current Investments rose 85.47% year-over-year to $4.0 billion; the TTM value through Dec 2025 reached $4.0 billion, up 85.47%, while the annual FY2025 figure was $4.0 billion, 85.47% up from the prior year.
  • Cash & Current Investments reached $4.0 billion in Q4 2025 per OSCR's latest filing, up from $3.0 billion in the prior quarter.
  • In the past five years, Cash & Current Investments ranged from a high of $4.0 billion in Q4 2025 to a low of $1.7 billion in Q3 2021.
  • Average Cash & Current Investments over 5 years is $2.8 billion, with a median of $2.8 billion recorded in 2022.
  • Peak YoY movement for Cash & Current Investments: skyrocketed 451.2% in 2021, then tumbled 30.04% in 2024.
  • A 5-year view of Cash & Current Investments shows it stood at $1.7 billion in 2021, then skyrocketed by 74.79% to $3.0 billion in 2022, then fell by 13.39% to $2.6 billion in 2023, then fell by 15.96% to $2.2 billion in 2024, then surged by 85.47% to $4.0 billion in 2025.
  • Per Business Quant, the three most recent readings for OSCR's Cash & Current Investments are $4.0 billion (Q4 2025), $3.0 billion (Q3 2025), and $3.5 billion (Q2 2025).